Effects of adiponectin on the gene promoter activities of fatty acid synthase and hormone sensitive lipase in HepG2 cells

Abstract

Abstract: Objective To investigate the effects of adiponectin on human FAS and HSL gene promoter activities in human hepatocarcinoma cell line HepG2 transfected with plasmids containing human FAS or HSL promoters fused to a luciferase reporter gene. Methods The luciferase reporter gene expression plasmids pGL3-hFAS625-Luc(hFAS 625-Luc) and pGL3-hHSL750-Luc (hHSL 750-Luc) were constructed. HepG2 cells were then transfected with these plasmids by lipofectamine method. The FAS and HSL promoter activities was evaluated by testing the luciferase activity through incubation with 0.5-10.0 μg/mL adiponectin) for 24 h or 5 μg/mL adiponectin for 2-32 h. Results Both hFAS 625-Luc and hHSL 750-Luc plasmids were well expressed in HepG2 cells. 1.0-10.0 μg/mL adiponectin could progressively increase the luciferase expression in HepG2 cells transfected with hFAS 625-Luc and hHSL 750-Luc plasmids with the maximum effect of 1.76 folds (P＜0.01) and 1.37 folds of the controls, respectively, at the concentration of 10.0 μg/mL(P＜0.01). Moreover, 5 μg/mL adiponectin promoted the expression of luciferase in HepG2 cells transfected with hFAS 625-Luc plasmids at 4 h and 8 h (P＜0.01), and inhibited the expression of luciferase at 16 h and 32 h (P＜0.01). Adiponectin promoted the expression of luciferase in HepG2 cells transfected with HSL 750-Luc within different durations(2~32 h), and the highest was 1.37 times of the control group at 2 h (P＜0.01). Conclusions The luciferase reporter gene plasmids containing human FAS and HSL promoters are successfully constructed. Adiponectin promotes FAS and HSL promoter activities in HepG2 cells with a dose-dependent manner. Adiponectin has a double effect on FAS promoter activity in different times, while it has a promoting effect on HSL promoter activity with different incubation durations.

Key words: adiponectin, fatty acid synthase(FAS), hormone sensitive lipase(HSL), HepG2 cell, promoter activity

CLC Number:

R589

XU Han-yuan, ZHU Hui-juan, PAN Hui, YANG Hong-bo, WANG Lin-jie, GONG Feng-ying. Effects of adiponectin on the gene promoter activities of fatty acid synthase and hormone sensitive lipase in HepG2 cells[J]. Basic & Clinical Medicine, 2021, 41(1): 13-19.

References

[1] Achari AE, Jain SK. Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction[J]. Int J Mol Sci, 2017, 18:1321-1337.
[2] Thanakun S, Pornprasertsuk-Damrongsri S, Izumi Y. Increased oral inflammation, leukocytes, and leptin, and lower adiponectin in overweight or obesity[J]. Oral Dis, 2017, 23: 956-965.
[3] Asterholm IW, Scherer PE. Enhanced metabolic flexibility associated with elevated adiponectin levels[J]. Am J Pathol, 2010, 176: 1364-1376.
[4] Simo R, Saez-Lopez C, Lecube A, et al. Adiponectin upregulates SHBG production: molecular mechanisms and potential implications[J]. Endocrinology, 2014, 155: 2820-2830.
[5] Saponaro C, Gaggini M, Carli F, et al. The subtle balance between lipolysis and lipogenesis: a critical point in metabolic homeostasis[J]. Nutrients, 2015, 7: 9453-9474.
[6] Wang SJ, Lu WY, Liu KY. Adiponectin receptor agonist AdipoRon suppresses adipogenesis in C3H10T1/2 cells through the adenosine monophosphate activated protein kinase signaling pathway[J]. Mol Med Rep, 2017, 16: 7163-7169.
[7] Wedellova Z, Kovacova Z, Tencerova M, et al. The impact of full-length, trimeric and globular adiponectin on lipolysis in subcutaneous and visceral adipocytes of obese and non-obese women[J]. PLoS One, 2013, 8: e66783. doi: 10.1371/journal.pone.0066783.
[8] Gong FY, Shi YF and Deng JY, et al. The regulatory mechanism by which interleukin-6 stimulates GH-gene expression in rat GH3 cells[J]. J Endocrinol, 2006, 190: 397-406.
[9] Yang W, Yang C, Luo J, et al. Adiponectin promotes preadipocyte differentiation via the PPAR gamma pathway[J]. Mol Med Rep, 2018, 17: 428-435.
[10] Liu Q, Yuan B, Lo KA, et al. Adiponectin regulates expression of hepatic genes critical for glucose and lipid metabolism[J]. Proc Natl Acad Sci U S A, 2012, 109: 14568-14573.
[11] Awazawa M, Ueki K, Inabe K, et al. Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway[J]. Biochem Biophys Res Commun, 2009, 382: 51-56.
[12] Chou IP, Lin YY, Ding ST, et al. Adiponectin receptor 1 enhances fatty acid metabolism and cell survival in palmitate-treated hepg2 cells through the pi3 k/akt pathway[J]. Eur J Nutr, 2014, 53: 907-917.
[13] Xu A, Wang Y, Keshaw H, et al. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice[J]. J Clin Invest, 2003, 112: 91-100.
[14] Ma Y. and Liu D. Hydrodynamic delivery of adiponectin and adiponectin receptor 2 gene blocks high-fat diet-induced obesity and insulin resistance[J]. Gene Ther, 2013, 20: 846-852.
[15] Fruebis J, Tsao TS, Javorschi S, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice[J]. Proc Natl Acad Sci U S A, 2001, 98: 2005-2010.
[16] de Mendonca M, Dos Santos BAC, de Sousa E, et al. Adiponectin is required for pioglitazone-induced improvements in hepatic steatosis in mice fed a high-fat diet[J]. Mol Cell Endocrinol, 2019, 493: 110480. doi: 10.1016/j.mce.2019.110480.